Long-Acting Contraceptive Designed to be Self-Administered Via Microneedle Patch
February 21, 2019
“We select polymer materials to meet specific design objectives such as microneedle strength, biocompatibility, biodegradation and drug release time, and formulation stability,” said Steven Schwendeman, the Ara Paul Professor and chair of the Department of Pharmaceutical Sciences at the University of Michigan and a collaborator on this project.
A new long-acting contraceptive designed to be self-administered by women may provide a new family planning option, particularly in developing nations where access to health care can be limited, a recent study suggests. The contraceptive would be delivered using microneedle skin patch technology originally developed for the painless administration of vaccines.
Dr. Tim Cernak Featured in Chemical and Engineering News
September 21, 2018
Tim Cernak, who previously developed a miniaturized high-throughput synthesis technique at Merck & Co. to explore reaction conditions and protein affinity, says the work is a “tour de force of hardware and software development.”
Chemists hand off reaction optimization to automated ‘plug and play’ flow system
Delivering Cancer Treatment on a Nanodisc Helps Eliminate Tumors
April 19, 2018
Left to right: Drs. James Moon and Anna Schwendeman
Novel platform for chemo-immunotherapy eliminated colon cancer in 85 percent of treated mice.
A New Treatment Strategy Against Metastatic Cancer
March 29, 2018
Left to right, Drs. Sejin Son and Jutaek Nam.

Despite decades of research, it has been challenging to develop an effective cancer therapy that can eliminate large solid tumors as well as metastatic tumors, while preventing recurrence.

Cheng Laboratory Featured on Cover of Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology
September 19, 2016
The cover artwork is a snapshot of a visualization of their experiments (Image credit: David Brennan).

Label-free detection and manipulation of single biological nanoparticles was selected as the cover artwork in the current issue of Wiley Interdisciplinary Reviews: Nanomedicine and Nanobio

FDA Awards $4.35 Million in Contracts to College of Pharmacy
February 8, 2016
The FDA has funded three separate contracts to Drs. Amidon, Schwendeman, and Sun, with an initial commitment of $4,348,178. Additional options would reach $14,766,472 in total funding if approved by the agency.

At the end of 2015, the US Food and Drug Administration (FDA) funded three separate contracts to Drs.

Newly Published Reports from the Rosania Research Group Describe Macrophages and their Drug-Sequestering Habits
August 14, 2015
Macrophages containing Clofazimine Drug Biocrystals

The Rosania Research Group at the College of Pharmacy has published four reports detailing the pharmacological, immunological, and optical analyses on macrophage-targeted drug sequestration.

Dr. Anna Schwendeman’s Research Honored; Project Selected for MTRAC Fast Forward
October 23, 2014
In February 2013, the U-M Medical School was awarded $2.4 million to help fund the U-M Michigan Translational Research and Commercialization for Life Sciences Program (U-M MTRAC). Of the 39 proposals submitted in its first year, the MTRAC Oversight Committee selected 11 for funding, including one by Dr. Anna Schwendeman, Assistant Professor of Medicinal Chemistry at the College of Pharmacy.
Faculty Receive Supplemental NIH Grant in Addressing Sex Differences Research
October 1, 2014
College of Pharmacy faculty members Dr. Vicki Ellingrod, John Gideon Searle Professor of Pharmacy and Associate Chair for Research Development and Mentorship in the Department of Clinical, Social, and Administrative Sciences, and Dr. Kathleen Stringer, Professor of Pharmacy in the Department of Clinical, Social and Administrative Sciences, received a supplemental grant from the National Institutes of Health (NIH).
Dr. Balkrishnan and Dr. Park Receive FDA Grant to Study Effectiveness of Immunosuppressant Medications
September 22, 2014
"This research represents an important extension of the ongoing research between the U-M Kidney Epidemiology and Cost Center (UM-KECC) and the College of Pharmacy,” states Dr. Balkrishnan.

Pages